1. GPCR/G Protein Apoptosis Metabolic Enzyme/Protease
  2. Adenosine Receptor Apoptosis PGC-1α
  3. LJ-2698

LJ-2698 是一种具有口服活性的腺苷 A3 受体 (Adenosine A3 Receptor) 拮抗剂。LJ-2698 可诱导巨噬细胞中抗炎细胞因子水平升高,还能显著增加肺部抗炎性 M2 型巨噬细胞数量。LJ-2698 可阻止小鼠肺泡腔扩大,恢复小鼠肺功能,抑制小鼠肺组织中的基质金属蛋白酶活性与肺细胞凋亡 (apoptosis)。LJ-2698 可预防糖尿病肾病小鼠的肾损伤,抑制小鼠的肾脂质蓄积,并提高肾组织中的 PGC1α 水平。LJ-2698 可用于肺气肿和糖尿病肾病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

LJ-2698

LJ-2698 Chemical Structure

CAS No. : 945457-84-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

LJ-2698 is an orally active adenosine A3 receptor antagonist. LJ-2698 induces increased levels of anti-inflammatory cytokines in macrophages and significantly elevates the number of anti-inflammatory M2 macrophages in the lung. LJ-2698 prevents alveolar cavity enlargement, restores pulmonary function, inhibits matrix metalloproteinase activity and pulmonary cell apoptosis in the lung tissues of mice. LJ-2698 prevents renal injury, inhibits renal lipid accumulation, and increases PGC1α levels in renal tissues of mice with diabetic nephropathy. LJ-2698 is applicable to the research of emphysema and diabetic nephropathy[1][2].

体外研究
(In Vitro)

LJ-2698 (0.1 μM, 72 h) 可恢复 LPS (HY-D1056) 刺激的 RAW 264.7 小鼠巨噬细胞中抗炎细胞因子 (Il4、Il10) 及 M2 型巨噬细胞标志物 (Arg1、Mrc1) 的表达[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Real Time qPCR[1]

Cell Line: RAW 264.7 (murine macrophage)
Concentration: 0.1 μM
Incubation Time: 48 h (pretreatment); 24 h (co-incubation with LPS)
Result: Significantly ameliorated LPS-mediated downregulation of Il4 and Il10 anti-inflammatory cytokine mRNA expression.
Significantly restored LPS-mediated downregulation of Arg1 and Mrc1 M2 macrophage marker mRNA expression.
体内研究
(In Vivo)

LJ-2698 (50 μg/kg;灌胃;每周 6 次;持续 5 周) 可通过恢复肺功能、减少气腔扩大、抑制基质金属蛋白酶活性及肺细胞凋亡、促进 M2 巨噬细胞介导的抗炎反应,显著抑制 Elastase, Porcine pancreas (HY-P2974) 诱导的 FVB 小鼠肺气肿,且观察到的毒性极低[1]
LJ-2698 (1.5-10 mg/kg;灌胃;每日一次;持续 12 周) 可呈剂量依赖性改善 db/db 小鼠的糖尿病肾病,其中 10 mg/kg 剂量在所有检测指标中均展现出最稳定且全面的肾脏保护作用[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: FVB mice (8-week-old)[1]
Dosage: 50 μg/kg
Administration: p.o.; 6 times per week; 5 weeks
Result: Restored lung compliance and tissue elasticity to levels closer to control mice.
Markedly suppressed PPE-induced airspace enlargement and reduced the elevated PPE-induced mean linear intercept (MLI).
Suppressed PPE-mediated increases in matrix metalloproteinase gelatinase activity in lung tissue.
Significantly reduced the number of TUNEL-positive apoptotic cells in the lungs compared to PPE-only treated mice.
Restored PPE-induced downregulation of anti-inflammatory cytokine (Il4, Il10) and M2 macrophage marker (Arg1, Mrc1/CD206) mRNA expression in lung tissue.
Increased the number of CD206-positive M2 macrophages per field in lung tissue.
Caused no significant changes in body weight compared to control or PPE-only groups, indicating minimal toxicity.
Animal Model: C57BLKS/J-db/db (male, 8 weeks old)[2]
Dosage: 1.5 mg/kg; 5 mg/kg; 10 mg/kg
Administration: p.o.; daily; 12 weeks
Result: Significantly reduced elevated glomerular volume and fractional mesangial area across all three doses, with no significant differences between doses.
Significantly reduced increased urinary albumin excretion at 5 and 10 mg/kg doses; did not produce a significant reduction at 1.5 mg/kg dose.
Significantly prevented reduced nephrin mRNA levels and increased NGAL mRNA levels at 10 mg/kg dose.
Significantly inhibited increased TGF-β mRNA levels at 10 mg/kg dose; did not produce a significant reduction at 1.5 and 5 mg/kg doses.
Significantly reduced increased collagen IV and fibronectin mRNA levels at 5 and 10 mg/kg doses.
Significantly reduced elevated MCP-1 mRNA levels at 5 and 10 mg/kg doses; significantly inhibited increased ICAM-1 mRNA levels at 10 mg/kg dose, while 1.5 and 5 mg/kg doses did not.
Significantly decreased increased urinary LPO levels at 5 and 10 mg/kg doses.
分子量

412.29

Formula

C16H15Cl2N5O2S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
LJ-2698
目录号:
HY-153149
需求量: